Comparing the efficacy of Myjet‐assisted tranexamic acid and vitamin C in treating melasma: A split‐face controlled trial
Comparing the efficacy of Myjet‐assisted tranexamic acid and vitamin C in treating melasma: A split‐face controlled trial
复制标题
DOI:
10.1111/jocd.13112
复制
发表时间:
2020-01
影响因子:
2.3
通讯作者:
Huijuan Zhao;Mengna Li;Xiaofeng Zhang;Li Li-Li;Yan Yan-Yan;Baoxi Wang
中科院分区:
文献类型:
--
作者:
Huijuan Zhao;Mengna Li;Xiaofeng Zhang;Li Li-Li;Yan Yan-Yan;Baoxi Wang
Melasma is a benign and chronic hypermelanosis characterized by irregular light brown to dark brown patches of hyperpigmentation on the skin. Oral tranexamic acid (TA) or vitamin C (VC) supplementation has been one treatment choice. TA interferes with keratinocyte‐melanocyte interactions, and VC functions by reducing melanin production resulting in skin rejuvenation and whitening.